UBS Group
NARI

UBS Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

UBS Group’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-146,035
Closed -$7.46M – 10990
2024
Q4 		$7.46M Buy
146,035
+65,566
+81% +$3.22M ﹤0.01% 3392
2024
Q3 		$3.32M Buy
80,469
+58,044
+259% +$2.79M ﹤0.01% 3480
2024
Q2 		$1.08M Sell
22,425
-13,499
-38% -$598K ﹤0.01% 4350
2024
Q1 		$1.72M Sell
35,924
-8,417
-19% -$450K ﹤0.01% 4087
2023
Q4 		$2.88M Buy
44,341
+21,444
+94% +$1.29M ﹤0.01% 3420
2023
Q3 		$1.5M Sell
22,897
-26,108
-53% -$1.64M ﹤0.01% 3728
2023
Q2 		$2.85M Buy
49,005
+22,625
+86% +$1.43M ﹤0.01% 3173
2023
Q1 		$1.63M Buy
26,380
+8,041
+44% +$482K ﹤0.01% 3642
2022
Q4 		$1.17M Buy
18,339
+14,896
+433% +$1.08M ﹤0.01% 3925
2022
Q3 		$250K Buy
3,443
+127
+4% +$9.46K ﹤0.01% 4900
2022
Q2 		$225K Sell
3,316
-4,645
-58% -$334K ﹤0.01% 4820
2022
Q1 		$722K Sell
7,961
-5,829
-42% -$477K ﹤0.01% 4410
2021
Q4 		$1.26M Buy
13,790
+10,609
+334% +$909K ﹤0.01% 4182
2021
Q3 		$258K Buy
3,181
+2,364
+289% +$199K ﹤0.01% 5142
2021
Q2 		$76K Sell
817
-4,832
-86% -$468K ﹤0.01% 6087
2021
Q1 		$605K Buy
5,649
+3,981
+239% +$413K ﹤0.01% 4723
2020
Q4 		$145K Buy
1,668
+1,040
+166% +$73.5K ﹤0.01% 5452
2020
Q3 		$43K Sell
628
-218
-26% -$14K ﹤0.01% 5765
2020
Q2 		$41K Buy
+846
New +$40.4K ﹤0.01% 6044

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

UBS Group's NARI Position: Q1 2025 in Review

UBS Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 146,035 shares — an estimated $7.46M sold.

UBS Group first reported a position in NARI in Q2 2020 and held it in 19 quarters. The position peaked at $7.46M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • UBS Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • UBS Group sold 146,035 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $7.46M.
  • UBS Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 19 quarters.
  • UBS Group's Inari Medical, Inc. Common Stock position peaked at $7.46M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.